Skip to main content

Clinical Features of Leprosy

  • Chapter
  • First Online:
Leprosy and Buruli Ulcer

Abstract

The wide range of cutaneous clinical features of leprosy arises from the interaction between Mycobacterium leprae and the cell-mediated immunity of patients; clinical aspects can be seen in a spectrum (Ridley–Jopling) which ranges from the tuberculoid (TT) hyperergic pole to the lepromatous (LL) anergic pole. TT is characterized by single or a few lesions (macules, plaques, and papules) grouped together, asymmetric arrangement, well-defined edges, and anesthetic dry surface. LL is characterized by large number of lesions (macules, plaques, and nodules), smooth surface, preserved sensitivity, presence of acid-fast bacilli (AFB), and symmetric distribution pattern. Between these two extreme forms, there is an interpolar or borderline group where it is possible to distinguish BT, BB, and BL. BT leprosy has anesthetic, asymmetric lesions (which include macules, plaques, and papules). In the middle part of the spectrum (BB form), there is high immunological instability with propensity for type 1 leprosy reaction. The BB form is clinically characterized by lesions with symmetric distribution, polymorphic aspect, and AFB presence in lesions. The BL form has symmetric arrangement of lesions (macules, plaques, and nodules), but they are fewer than in the anergic LL form and they contain AFB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sehgal VN, Srivastava G. Indeterminate leprosy. A passing phase in the evolution of leprosy. Lepr Rev. 1987;58:291–4.

    CAS  PubMed  Google Scholar 

  2. Nunzi E, Fiallo P. Leprosy: a dichotomous disease. Eur J Dermatol. 1995;5:649–52.

    Google Scholar 

  3. Noto S, Clapasson A, Nunzi E. Classification of leprosy: the mystery of “reactional tuberculoid”. G Ital Dermatol Venereol. 2007;142:294–5.

    Google Scholar 

  4. WHO Expert Committee on Leprosy. WHO Technical report series n. 874. Seventh report; 1988. p. 7.

    Google Scholar 

  5. Uplekar MW, Antia NH. Clinical and histopathological observations on pure neuritic leprosy. Indian J Lepr. 1986;58:513–21.

    CAS  PubMed  Google Scholar 

  6. Jopling WH. Borderline (dimorphous) leprosy maintaining a polyneuritic form for eight years: a case report. Trans R Soc Trop Med Hyg. 1956;50:478–80.

    Article  CAS  Google Scholar 

  7. Yoder LJ, Jacobson RR, Job CK. A single skin lesion—an unusual presentation of lepromatous leprosy. Int J Lepr. 1985;53:554–8.

    CAS  Google Scholar 

  8. Mascaro JM, Ferrando J, Gratacos R. Lepromatous leprosy clinically localized to one-half of the face. Report of a case. Int J Lepr. 1981;49:315–6.

    CAS  Google Scholar 

  9. Maroja MF, Lima LL, Pereira PMR, De Oliveira RML, Massone C. Zoster-like segmental presentation of Lepromatous leprosy. Lepr Rev. 2010;81(3):224–7.

    Article  Google Scholar 

  10. Taylor PM. The clinical diagnosis of dapsone resistant leprosy. Lepr India. 1982;54:117–22.

    CAS  PubMed  Google Scholar 

  11. Price EW, Fitzhebert M. Histoid (high-resistance) lepromatous leprosy. Int J Lepr. 1966;34:367–74.

    CAS  Google Scholar 

  12. Kroll JJ, Shapiro L. The histoid variety of lepromatous leprosy. Int J Dermatol. 1973;13:74–8.

    Article  Google Scholar 

  13. Azulay-Abulafia L, Pereira Spinelli L, Hardmann D, et al. Lucio phenomenon. Vasculitis or occlusive vasculopathy? Hautartz. 2006;57:1101–5.

    Article  CAS  Google Scholar 

  14. Nunzi E, Ortega Cabrera LV, Macanchi Monca Yo FM, Ortega Espinosa PF, Clapasson A, Massone C. Lucio Leprosy with Lucio’s phenomenon, digital gangrene and cardiolipin antibodies. Lepr Rev. 2014;85:194–200.

    Article  Google Scholar 

  15. Fiallo P, Travaglino C, Nunzi E, et al. Beta2-glycoprotein I-dependence of cardiolipin antibodies in multibacillary leprosy patients. Lepr Rev. 1998;69:376–81.

    CAS  PubMed  Google Scholar 

  16. WHO. Guidelines for the diagnosis, treatment and prevention of leprosy; 2018.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enrico Nunzi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nunzi, E., Massone, C., Noto, S. (2022). Clinical Features of Leprosy. In: Nunzi, E., Massone, C., Portaels, F. (eds) Leprosy and Buruli Ulcer. Springer, Cham. https://doi.org/10.1007/978-3-030-89704-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-89704-8_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-89703-1

  • Online ISBN: 978-3-030-89704-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics